Advertisement
Research Article Free access | 10.1172/JCI118197
St. George's Hospital Medical School, University of London, United Kingdom.
Find articles by Zaidi, M. in: JCI | PubMed | Google Scholar
St. George's Hospital Medical School, University of London, United Kingdom.
Find articles by Shankar, V. in: JCI | PubMed | Google Scholar
St. George's Hospital Medical School, University of London, United Kingdom.
Find articles by Tunwell, R. in: JCI | PubMed | Google Scholar
St. George's Hospital Medical School, University of London, United Kingdom.
Find articles by Adebanjo, O. in: JCI | PubMed | Google Scholar
St. George's Hospital Medical School, University of London, United Kingdom.
Find articles by Mackrill, J. in: JCI | PubMed | Google Scholar
St. George's Hospital Medical School, University of London, United Kingdom.
Find articles by Pazianas, M. in: JCI | PubMed | Google Scholar
St. George's Hospital Medical School, University of London, United Kingdom.
Find articles by O'Connell, D. in: JCI | PubMed | Google Scholar
St. George's Hospital Medical School, University of London, United Kingdom.
Find articles by Simon, B. in: JCI | PubMed | Google Scholar
St. George's Hospital Medical School, University of London, United Kingdom.
Find articles by Rifkin, B. in: JCI | PubMed | Google Scholar
St. George's Hospital Medical School, University of London, United Kingdom.
Find articles by Venkitaraman, A. in: JCI | PubMed | Google Scholar
Published September 1, 1995 - More info
Ryanodine receptors (RyRs) reside in microsomal membranes where they gate Ca2+ release in response to changes in the cytosolic Ca2+ concentration. In the osteoclast, a divalent cation sensor, the Ca2+ receptor (CaR), located within the cell's plasma membrane, monitors changes in the extracellular Ca2+ concentration. Here we show that a RyR-like molecule is a functional component of this receptor. We have demonstrated that [3H] ryanodine specifically binds to freshly isolated rat osteoclasts. The binding was displaced by ryanodine itself, the CaR agonist Ni2+ and the RyR antagonist ruthenium red. The latter also inhibited cytosolic Ca2+ elevations induced by Ni2+. In contrast, the responses to Ni2+ were strongly potentiated by an antiserum Ab129 raised to an epitope located within the channel-forming domain of the type II RyR. The antiserum also stained the surface of intact, unfixed, trypan blue-negative osteoclasts. Serial confocal sections and immunogold scanning electron microscopy confirmed a plasma membrane localization of this staining. Antiserum Ab34 directed to a putatively intracellular RyR epitope expectedly did not stain live osteoclasts nor did it potentiate CaR activation. It did, however, stain fixed, permeabilized cells in a distinctive cytoplasmic pattern. We conclude that an RyR-like molecule resides within the osteoclast plasma membrane and plays in important role in extracellular Ca2+ sensing.
Images.